 |
市场调查报告书
商品编码
1789444
重组蛋白市场按产品类型、表达系统、应用、最终用户和地区划分Recombinant Protein Market, by Product Type, by Expression System, by Application, by End User, by Region |
||||||
价格
简介目录
重组蛋白市场规模预计在 2025 年达到 38.925 亿美元，预计到 2032 年将达到 83.397 亿美元，2025 年至 2032 年的复合年增长率为 11.5%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 38.925亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年 | 11.50% | 2032年预测 | 83.397亿美元 |
重组蛋白是由重组DNA编码的蛋白质，该DNA克隆到支持基因表现和传讯RNA翻译的表达载体中。透过重组DNA技术进行基因改造可以表现突变蛋白。重组蛋白是天然蛋白质的工程化形式，可以透过多种方式生产，以提高蛋白质产量、改变基因序列并生产有用的商业产品。
许多重组蛋白需要并描述了转译后修饰，例如糖基化，而这些修饰仅在真核生物、酵母、哺乳动物或昆虫细胞培养系统中进行。 HEK293衍生细胞株用于瞬时蛋白生产。目前，大多数重组治疗性蛋白质是在哺乳动物细胞中生产的，因为它们能够生产与自然界中发现的蛋白质类似的高品质蛋白质。此外，许多核准的重组治疗性蛋白质是在大肠桿菌中生产的，因为它们具有明确的遗传结构、快速生长和高产量。
市场动态
该公司正专注于采取收购和合作等策略，以在全球市场奠定坚实的基础。例如，赛默飞世尔科技于2021年12月收购了重组蛋白开发和製造公司PeproTech。此次收购将增强赛默飞世尔科技的重组蛋白产品组合。
预计在预测期内，重组激素生技药品许可申请的监管核准将不断增加，从而推动市场成长。例如，2022年1月，跨国製药和生物技术公司辉瑞公司和生物技术公司OPKO Health, Inc.宣布，美国食品药物管理局(FDA)已为其somatrogon的生技药品许可申请(BLA)签发了完整反应报告(CRL)。 somatrogon是一种每週一次的长效重组人体生长荷尔蒙，用于治疗儿童生长激素缺乏症(GHD)。
本次调查的主要特点
- 本报告对全球重组蛋白市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模（百万美元）和年复合成长率（CAGR%）。
- 它揭示了不同领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 主要公司简介包括公司亮点、产品系列、关键亮点、业绩和策略。主要公司包括默克集团 (Merck KGaA)、傲锐东源科技 (OriGene Technologies, Inc.)、Feldan Therapeutics、ACROBiosystems、Abcam plc.、朗道实验室 (Randox Laboratories Ltd.)、SOL GROUP、Proteintech Group, Inc.、Planet BIoINology Inc. (GenScript)、BTL BIoTechno Labs Pvt Ltd.、Prospec-Tany Technogene Ltd.、BPS Bioscience, Inc.、义翘神州 (Sino Biological)、Cape Bio Pharms、上诺华 (Abnova Corporation) 和 GeNext Genomics。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球重组蛋白市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球重组蛋白市场所使用的各种策略矩阵更轻鬆地做出决策。
目录
第一章：调查目标和先决条件
- 调查目的
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图（COM）
第三章：市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 抑制因素
- 市场吸引力分析
- 市场机会
- 产品发布
- 合併、收购和合作
- 监理指南与合规性
- 政府干预
- PEST分析
- 科技
- 品牌属性映射
- 投资
- 价格分析（2021年）
4. 2020 年至 2032 年全球重组蛋白市场（依产品类型）
- 介绍
- 抗体
- 抗原
- 酵素
- 荷尔蒙
- 其他的
5. 2020 年至 2032 年全球重组蛋白市场（依表现系统划分）
- 介绍
- 微生物
- 植物
- 动物
6. 2020 年至 2032 年全球重组蛋白市场应用状况
- 介绍
- 药物研发
- 研究应用
- 治疗用途
- 诊断
- 其他的
7. 2020 年至 2032 年全球重组蛋白市场（依最终用户划分）
- 介绍
- 生物技术和製药公司
- 学术研究机构
- 合约研究组织
- 其他的
8. 2020 年至 2032 年全球重组蛋白市场（按地区）
- 介绍
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第九章 竞争态势
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet BIoTechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL BIoTechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
第 10 章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI1516
Recombinant Protein Market is estimated to be valued at USD 3,892.5 Mn in 2025 and is expected to reach USD 8,339.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3,892.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.50% | 2032 Value Projection: | USD 8,339.7 Mn |
A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.
Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.
Market Dynamics
The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.
The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.
Key features of the study
- This report provides in-depth analysis of the global recombinant protein market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.
Market Segmentation
- Global Recombinant Protein Market, By Product Type
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
- Global Recombinant Protein Market, By Expression System
- Microbes
- Plant
- Animal
- Global Recombinant Protein Market By Application
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
- Global Recombinant Protein Market By End User
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institute
- Contract Research Organization
- Others
- Global Recombinant Protein Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet Biotechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL Biotechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Expression System
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Government Intervention
- PEST Analysis
- Technology Landscape
- Brand Attribute Mapping
- Investments
- Pricing Analysis (2021)
4. Global Recombinant Protein Market, By Product Type, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Recombinant Protein Market, By Expression System, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microbes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Recombinant Protein Market, By Application, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Therapeutic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Recombinant Protein Market, By End User, 2020 - 2032, (USD Mn
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Recombinant Protein Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Feldan Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Proteintech Group, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Planet Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- INFINITE ENZYMES, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORF Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BTL Biotechno Labs Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Prospec-Tany Technogene Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BPS Bioscience, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cape Bio Pharms
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GeNext Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
日本重组蛋白市场报告（按产品、应用、最终用户和地区）2025-2033
全球重组蛋白药物市场：市场规模（按类型、应用和地区划分）、未来预测2025 年至 2033 年重组蛋白市场报告（按产品、应用、最终用户和地区）
重组促红血球生成素市场：依药物类型、应用、通路和地区划分
重组尿酸酶市场按产品类型、给药途径、应用和最终用户划分 - 2025 年至 2030 年全球预测
研究蛋白质市场规模、份额、趋势分析报告：按产品、宿主细胞、最终用途、地区和细分市场预测，2025 年至 2030 年
重组蛋白市场规模、份额和成长分析（按产品、按应用、按地区）：产业预测（2024-2031）
全球抗体/重组蛋白 CDMO 市场：按类型、来源类型、生产规模、应用、最终用户、地区 - 趋势分析、竞争格局、预测（2019-2030）重组蛋白市场：依产品、服务、最终用户、功能分类 - 2025-2030 年全球预测重组蛋白市场规模、份额、趋势分析报告：按产品、应用、最终用途、宿主细胞、地区、细分市场预测，2025-2030 年
▼